Clinical Trial

Effect of Tai Chi and Multimodal Exercise in Overweight and Obese Women

Completed
View on ClinicalTrials.gov →
Summary
Obesity is a health problem that results from the interaction of genetic, socio-economic, and socio-cultural factors, leading to excessive accumulation of body fat that harms the body and poses a risk to health. Excess weight and obesity negatively affect the musculoskeletal system, leading to limitations associated with physical functionality. In overweight and obese individuals, the musculoskeletal system experiences increased stress on bones, joints, and soft tissues. This causes balance and gait disorders, frequently leading to injuries from falls. Regular exercise is known to play a significant role in regulating energy balance, reducing the risk of obesity-related health problems, and decreasing the morbidity and mortality associated with these problems. However, while the literature shows numerous weight-focused studies on excess weight and obesity, intervention and comparative studies aimed at improving balance ability as a primary goal affecting an individual's physical mobility are limited. Furthermore, studies examining the effects of tai chi and multimodal exercise training on overweight and obese individuals are also limited. In the present study, it is aimed to examine the effects of a 10-week Tai Chi and Multimodal exercise program on balance in overweight and obese women, and to compare the effectiveness of Tai Chi and Multimodal exercises. The results of this study can guide the development of exercise programs to be used in the treatment of obesity and provide a scientific basis for creating more effective and sustainable rehabilitation strategies in the long term.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-04-11; most recent amendment 2026-06-18.
Trial Details
NCT Number NCT07536893
Lead Sponsor Pamukkale University
Conditions Overweight and Obesity
Enrollment 66 participants
Start Date 2025-02-21
Primary Completion 2025-04-11 (estimated)
Study Completion 2025-06-23 (estimated)
Updated on ClinicalTrials.gov 2026-06-23